Intelligent Fluid Control Systems for Enhanced Bodily Fluid Sampling
Legal Citation
Summary of the Inventive Concept
A next-generation fluid control system integrating machine learning, nanofiltration, and real-time contamination monitoring to provide highly accurate and personalized bodily fluid sampling, reducing contaminants and improving diagnostic outcomes.
Background and Problem Solved
The original patent addresses the issue of contaminants in bodily fluid samples, but its limitations include the lack of adaptability to individual patient needs and the potential for human error. The new inventive concept tackles these limitations by incorporating advanced technologies to create a more intelligent and efficient fluid control system.
Detailed Description of the Inventive Concept
The system comprises a fluid control device, a machine learning module, and a nanofiltration unit. The fluid control device receives an initial volume of bodily fluid and sequesters contaminants therein. The machine learning module predicts the likelihood of contamination based on patient-specific data and adjusts the sequestration process accordingly. The nanofiltration unit removes contaminants from the initial volume, and a sensor detects contaminants in real-time, adjusting the nanofiltration process accordingly. The system can be integrated with a cloud-based analytics platform for analyzing sensor data and providing recommendations for optimal sequestration parameters.
Novelty and Inventive Step
The integration of machine learning, nanofiltration, and real-time contamination monitoring in a fluid control system is a novel and non-obvious advancement over the original patent. The use of patient-specific data to predict contamination likelihood and adjust the sequestration process in real-time is a significant inventive step.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different machine learning algorithms, various nanofiltration materials, or alternative sensor technologies. Variations may include the integration of robotic arms for automated fluid control device adjustment or the use of blockchain technology for secure data storage and analysis.
Potential Commercial Applications and Market
The intelligent fluid control system has significant commercial potential in the healthcare industry, particularly in the fields of diagnostic testing, personalized medicine, and precision health. The system's ability to reduce contaminants and improve diagnostic outcomes can lead to increased adoption in hospitals, clinics, and research institutions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically fluid sampling systems, diagnostic device design, and medical instrumentation with expertise in microfluidics, contamination control, and sample processing technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degree, 3-5 years professional experience in medical device design, familiar with microfluidic systems, contamination mitigation techniques, and emerging diagnostic technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's machine learning and sensor-based contamination monitoring represent predictable extensions of the source patent's core fluid sequestration methodology. The fundamental goal of reducing bodily fluid contamination remains consistent, with the PTD introducing incremental technological enhancements using known machine learning and sensor integration techniques. These variations represent logical technological progressions that would be obvious to a skilled practitioner seeking to improve fluid sampling precision.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,321 |
|---|---|
| Title | Fluid control devices and methods of using the same |
| Assignee(s) | Magnolia Medical Technologies, Inc. |